Actinogen Medical Limited
ATGGF
$0.03
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -81.83% | -40.80% | -12.08% | 13.10% | 34.84% |
| Total Depreciation and Amortization | 3.16% | 0.85% | -0.07% | -1.42% | -2.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -160.48% | -124.82% | 59.69% | 178.57% | 269.80% |
| Change in Net Operating Assets | 187.19% | 187.19% | 187.19% | 85.83% | -4,253.71% |
| Cash from Operations | -84.04% | 9.07% | 57.37% | 46.25% | 31.07% |
| Capital Expenditure | -306.67% | -326.32% | -348.15% | -37.61% | 63.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -306.67% | -326.32% | -348.15% | -37.61% | 63.86% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3,979.95% | -1,820.05% | 33.99% | 19.89% | 4.14% |
| Issuance of Common Stock | -98.45% | -68.92% | -35.95% | 15.37% | 113.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 75.97% | 50.22% | -10.01% | -151.26% |
| Cash from Financing | -99.90% | -62.17% | -18.43% | 27.40% | 114.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -240.27% | -170.56% | 658.59% | 975.25% | 458.34% |